CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 130 enrolled
Drug / intervention
Hand Grip Strength Measurementother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07167082
NCT07167082N/ACompleted

Hospitalized Cancer Patients: Prognostic Value of Hand Grip Strength - A Prospective Cohort Study

Ankara Etlik City Hospital·observational·Posted Sep 11, 2025·Updated Sep 11, 2025

In Brief

An observational study evaluating Hand Grip Strength Measurement for Cancer and 3 related conditions. Completed, enrolled 130 participants across 1 site.

Detailed Summary

This prospective cohort study aims to investigate the relationship between hand grip strength and prognosis in hospitalized cancer patients. Hand grip strength, a simple, rapid, and non-invasive measure of overall muscle function, is increasingly recognized as an indicator of frailty, nutritional status, and physical health. The study will evaluate whether lower hand grip strength is associated with higher short-term mortality (30-day all-cause mortality) and adverse clinical outcomes, including ICU admission, hospital readmission, and functional decline.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesTurkey (Türkiye)
Collaborators--

Timeline

N/ACompletedFinished
20252026
First PostedSep 11, 2025
Enrollment StartSep 1, 2024
Primary CompletionOct 20, 2024
Study CompletionMar 25, 2025
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 10 months ago

Interventions

Hand Grip Strength Measurementother

Hand grip strength will be measured within the first 24 hours of hospitalization using a calibrated hand dynamometer. Measurements will be performed on the dominant hand, with patients seated, following standardized international procedures. Three consecutive measurements will be obtained, and the average value will be recorded. The test is non-invasive, quick, and performed by oncology clinicians trained in the protocol.